SEC Form 4 · accession 0000899243-16-020299
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin P Starr
Director · 10% Owner
Period of report
May 16, 2016
Accepted (ET)
May 18, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2016 | S | 850,000 | $31.25 | D | 3,892,916 | I | See Footnote |
| Common Stock | holding | — | — | — | 65,227 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are directly held by Third Rock Ventures II, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP II, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP II, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin, the Reporting Person and Dr. Robert Tepper. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.